Cellebrite DI ( (CLBT) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cellebrite DI’s stock price is on the rise following JPMorgan’s decision to increase its price target to $23. This adjustment comes as a result of stable to improving macro conditions for security software, as well as recent earnings reports that highlight the company’s resilience in markets with substantial enterprise budgets and high-priority spending. Furthermore, Cellebrite’s strategic positioning keeps it on JPMorgan’s Analyst Focus List.
More about Cellebrite DI
YTD Price Performance: -17.59%
Average Trading Volume: 1,907,226
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.3B
For further insights into CLBT stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.